BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 38508608)

  • 41. Cancer screening rates among transgender adults: Cross-sectional analysis of primary care data.
    Kiran T; Davie S; Singh D; Hranilovic S; Pinto AD; Abramovich A; Lofters A
    Can Fam Physician; 2019 Jan; 65(1):e30-e37. PubMed ID: 30674526
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cervicovaginal Papanicolaou tests in transgender men: Cytomorphologic alterations, interpretation considerations, and clinical implications.
    Torous VF
    Cancer Cytopathol; 2023 Oct; 131(10):626-636. PubMed ID: 37358041
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Enacting power and constructing gender in cervical cancer screening encounters between transmasculine patients and health care providers.
    Peitzmeier SM; Bernstein IM; McDowell MJ; Pardee DJ; Agénor M; Alizaga NM; Reisner SL; Potter J
    Cult Health Sex; 2020 Dec; 22(12):1315-1332. PubMed ID: 31661659
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Role of various screening techniques in detecting preinvasive lesions of the cervix among symptomatic women and women having unhealthy cervix.
    Nayak PK; Mitra S; Agrawal S; Hussain N; Thakur P; Mishra B
    J Cancer Res Ther; 2021; 17(1):180-185. PubMed ID: 33723152
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pap test use is lower among female-to-male patients than non-transgender women.
    Peitzmeier SM; Khullar K; Reisner SL; Potter J
    Am J Prev Med; 2014 Dec; 47(6):808-12. PubMed ID: 25455121
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Early detection of precursors of cervical cancer with cervical cytology and visual inspection of cervix with acetic Acid.
    Dhaubhadel P; Vaidya A; Choudhary P
    JNMA J Nepal Med Assoc; 2008; 47(170):71-6. PubMed ID: 18709035
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Navigating trans visibilities, trauma and trust in a new cervical screening clinic.
    Gibson AF; Drysdale K; Botfield J; Mooney-Somers J; Cook T; Newman CE
    Cult Health Sex; 2022 Oct; 24(10):1366-1379. PubMed ID: 34506266
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Gender-affirming hormones and surgery in transgender children and adolescents.
    Mahfouda S; Moore JK; Siafarikas A; Hewitt T; Ganti U; Lin A; Zepf FD
    Lancet Diabetes Endocrinol; 2019 Jun; 7(6):484-498. PubMed ID: 30528161
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Benefit and burden in the Dutch cytology-based vs high-risk human papillomavirus-based cervical cancer screening program.
    Loopik DL; Koenjer LM; Siebers AG; Melchers WJG; Bekkers RLM
    Am J Obstet Gynecol; 2021 Feb; 224(2):200.e1-200.e9. PubMed ID: 32800820
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Initiation of Gender-Affirming Testosterone Therapy in a Lactating Transgender Man.
    Oberhelman-Eaton S; Chang A; Gonzalez C; Braith A; Singh RJ; Lteif A
    J Hum Lact; 2022 May; 38(2):339-343. PubMed ID: 34490813
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Amplification of specific chromosomal regions assessed by fluorescent in situ hybridization on Pap smears to be added as screening tool for identifying women at risk of progressing to cervical cancer.
    Upendram P; Sahni S; Mohiuddin K; Poornima S; Gourishankar B; Kumar Vattam K; Boddala P; Jayashankar E; Mohiuddin S; Kamineni V; Mohan V; Houldsworth J; Hasan Q
    Tumour Biol; 2017 Oct; 39(10):1010428317698363. PubMed ID: 28990460
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Gender-Affirming Hormone Pharmacokinetics Among Adolescent and Young Adult Transgender Persons Receiving Daily Emtricitabine/Tenofovir Disoproxil Fumarate.
    Yager J; Brooks KM; Brothers J; Mulligan K; Landovitz RJ; Reirden D; Malhotra M; Glenny C; Harding P; Powell T; Anderson PL; Hosek S
    AIDS Res Hum Retroviruses; 2022 Dec; 38(12):939-943. PubMed ID: 35815468
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cervicography: adjunctive cervical cancer screening by primary care clinicians.
    Ferris DG; Payne P; Frisch LE; Milner FH; diPaola FM; Petry LJ
    J Fam Pract; 1993 Aug; 37(2):158-64. PubMed ID: 8336097
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cytology of the neovagina in transgender women and individuals with congenital or acquired absence of a natural vagina.
    Grosse A; Grosse C; Lenggenhager D; Bode B; Camenisch U; Bode P
    Cytopathology; 2017 Jun; 28(3):184-191. PubMed ID: 28217933
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The IMproving Primary Screening And Colposcopy Triage trial: human papillomavirus, cervical cytology, and histopathologic results from the baseline and 1-year follow-up phase.
    Safaeian M; Wright TC; Stoler MH; Ranger-Moore J; Rehm S; Aslam S; Fang Q; Volkir P; Ridder R
    Am J Obstet Gynecol; 2021 Sep; 225(3):278.e1-278.e16. PubMed ID: 33852886
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Detection of human papillomavirus DNA in routine cervical scraping samples: use for a national cervical cancer screening program in a developing nation.
    Othman N; Othman NH
    Asian Pac J Cancer Prev; 2014; 15(5):2245-9. PubMed ID: 24716964
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Functional ovarian reserve in transgender men receiving testosterone therapy: evidence for preserved anti-Müllerian hormone and antral follicle count under prolonged treatment.
    Yaish I; Tordjman K; Amir H; Malinger G; Salemnick Y; Shefer G; Serebro M; Azem F; Golani N; Sofer Y; Stern N; Greenman Y
    Hum Reprod; 2021 Sep; 36(10):2753-2760. PubMed ID: 34411251
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Breast and reproductive cancers in the transgender population: a systematic review.
    Joint R; Chen ZE; Cameron S
    BJOG; 2018 Nov; 125(12):1505-1512. PubMed ID: 29706033
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Persistence and clearance of high-risk human papillomavirus and cervical dysplasia at 1 year in women living with human immunodeficiency virus: a prospective cohort study.
    Luckett R; Painter H; Hacker MR; Simon B; Seiphetlheng A; Erlinger A; Eakin C; Moyo S; Kyokunda LT; Esselen K; Feldman S; Morroni C; Ramogola-Masire D
    BJOG; 2021 Nov; 128(12):1986-1996. PubMed ID: 34008294
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical needs for transgender men in the gynecologic oncology setting.
    Stenzel AE; Moysich KB; Ferrando CA; Starbuck KD
    Gynecol Oncol; 2020 Dec; 159(3):899-905. PubMed ID: 33004214
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.